论文部分内容阅读
目的 :探讨肝癌合并门静脉高压症施行联合手术的可行性 ,手术方式及手术适应证。方法 :筛选2 0例施行联合手术治疗的肝癌合并门静脉高压症病人作回顾性临床分析。结果 :术后并发中等量腹水 5例 ,胸腔积液 4例 ,膈下脓肿 1例 ,1例术后 2周死于肝肾衰竭 ,11例出院后均死于肝癌复发 ,无食管胃底曲张静脉破裂出血死亡 ,此死亡的 12例病人平均生存 2 0 .2 9个月。另 8例术后至今仍然存活 ,生活均能自理 ,其中 1例术后 40月余仍带瘤生存。结论 :只要合理掌握手术适应证和手术方式 ,对肝癌合并门静脉高压症施行联合手术治疗是安全可行的
Objective: To investigate the feasibility, operation method and operation indications of hepatocellular carcinoma combined with portal hypertension. Methods: A retrospective clinical analysis of 20 patients with hepatocellular carcinoma complicated by portal hypertension who underwent combined surgery was screened. Results: There were 5 cases of moderate ascites, 4 cases of pleural effusion, 1 case of subphrenic abscess, 1 case died of liver and kidney failure 2 weeks after operation, 11 cases died of recurrence of hepatocellular carcinoma after discharge, Bleeding ruptured venous death, the death of 12 patients with an average survival of 20.29 months. The other 8 cases still survived the postoperative life can take care of themselves, of which 1 case still alive after 40 months. Conclusion: As long as the surgical indications and surgical procedures are properly controlled, it is safe and feasible to perform combined surgery on HCC with portal hypertension